NCT00444353View on ClinicalTrials.gov

DL6049 Versus Cosmoplast in the Treatment of Nasolabial Fold Wrinkles, Long Term Follow-up

PHASE3CompletedINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

August 31, 2004

Study Completion Date

January 31, 2007

Conditions
Nasolabial Fold Wrinkles
Interventions
DEVICE

DL6049 (injectable poly-L-lactic acid)

Trial Locations (1)

08807

Sanofi-Aventis, Bridgewater

All Listed Sponsors
lead

Bausch Health Americas, Inc.

INDUSTRY

NCT00444353 - DL6049 Versus Cosmoplast in the Treatment of Nasolabial Fold Wrinkles, Long Term Follow-up | Biotech Hunter | Biotech Hunter